Available Clinical Trials

Clinical Research is an integral part of oncology at Bon Secours Richmond Health System. Clinical trials give patients access to the newest and best treatments for cancer. Bon Secours Richmond Health System is proud to provide the same options as leading national cancer centers. Whether it is looking at new surgical or radiation interventions, or giving a brand new medication, We are striving to find better ways to treat, prevent, and manage cancer.

To inquire about participation in a clinical trial, please contact us at (804) 893-8717.

Please see the available, in-progress clinical trials at Bon Secours Richmond Health System. You may filter these results by searching by disease type or keyword.

Search Clinical Trials

Select Category      or   

Displaying All Clinical Trials (25)
alliance-a011202
A Randomized Trial Evaluating The Role Of Axillary Lymph Node Dissecti...
alliance-a011401
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuv...
alliance-a011502
Randomized Phase III Double Blinded Placebo Controlled Trial of Aspiri...
alliance-a021502
Randomized Trial of Standard Chemotherapy Alone or Combined with Atezo...
alliance-a031501
Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) in m...
alliance-aft-28
CANVAS Trial Cancer‐related VTE Anticoagulation Strategies Direct Or...
alliance-alchemist-trials-a081105
Randomized Double Blind Placebo Controlled Study Of Erlotinib Or Place...
alliance-alchemist-trials-a151216
Receptor (EGFR) Mutant Non‐small Cell Lung Cancer (NSCLC)...
alliance-alchemist-trials-e4512
A Phase III Double‐Blind Trial for Surgically Resected Early Stage N...
alliance-alchemist-trials-ea5142
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)‐A Randomized Pha...
boston-biomedical-canstem111p
A Phase III Study of BBI-608 Plus Nab-Paclitaxel With Gemcitabine in A...
ecog-acrin-e2112
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Plac...
ecog-acrin-eay131
NCI‐Molecular Analysis For Therapy Choice Program (NCI‐ MATCH)...
merck-522
A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab ...
nrg-oncology-nrg-br002
A Phase IIR/III Trial of Standard of Care Therapy with or without Ster...
nrg-oncology-nrg-br003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin...
nrg-oncology-nsabp-b-55big-6-13
A Randomized, Double‐Blind, Parallel Group, Placebo‐ Controlled Mu...
pfizer-a5481074

Prospective Observational Study of Mobile App-Based Pa...

pfizer-a5481082
POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Canc...
rexahn-rx-5902
A Multi-Center, Dose Finding, Open Label, Phase 1 Study of RX-5902 in ...
rtog-0924
Androgen Deprivation Therapy and High Dose Radiotherapy With or Withou...
swog-s1207
Phase III Randomized, Placebo‐Controlled Clinical Trial Evaluating t...
swog-s1400-g-i
Phase II/III Biomarker‐Driven Master Protocol for Second Line Therap...
swog-s1418
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of M...
unc-lccc-1317
Genotype‐directed Phase II Study of Irinotecan Dosing in Metastatic ...

Showing 10 of 20